|
|
Elena Koustova, Yoshitatsu Sei, Linda Fossom, Mei-Ling Wei, Peter N.R. Usherwood, N. Bradley Keele, Michael A. Rogawski, Anthony S. Basile
J Clin Invest. 2001;
107(6):737
doi:10.1172/JCI11500
Abstract |
Full text
| PDF

A
utoantibodies to α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors may contribute to chronic hyperexcitability syndromes and neurodegeneration, but their origin is unclear. We examined LP-BM5 murine leukemia virus–infected mice, which manifest excitotoxic brain lesions and hypergammaglobulinemia, for the presence of AMPA-receptor Ab’s. Endogenous IgG accumulated upon neurons in the neocortex and caudate/putamen of infected mice and interacted with native and recombinant AMPA-receptor subunits with the following relative abundance: GluR3 ≥ GluR1 > GluR2 = GluR4, as determined by immunoprecipitation. In a radioligand assay, IgG preparations from infected mice specifically inhibited [3H]AMPA binding to receptors in brain homogenates, an activity that was lost after preadsorbing the IgG preparation to immobilized LP-BM5 virus. These IgGs also evoked currents when applied to hippocampal pyramidal neurons or to damaged cerebellar granule neurons. These currents could be blocked using any of several AMPA receptor antagonists. Thus, anti–AMPA-receptor Ab’s can be produced as the result of a virus infection, in part through molecular mimicry. These Ab’s may alter neuronal signaling and contribute to the neurodegeneration observed in these mice, actions that may be curtailed by the use of AMPA-receptor antagonists.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(8)
| Title and authors |
Publication |
Year |
The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms
J.Y. Rotge, B. Aouizerate, J. Tignol, B. Bioulac, P. Burbaud, D. Guehl
|
Neuroscience
|
2010 |
Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis
Mia Levite, Yonatan Ganor
|
Expert Rev Neurotherapeutics
|
2008 |
Long term response to steroid therapy in Rasmussen encephalitis
N. Bahi-Buisson, V. Villanueva, C. Bulteau, O. Delalande, O. Dulac, C. Chiron, R. Nabbout
|
Seizure
|
2007 |
No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3—antibodies
Michael Feichtinger, Heinz Wiendl, Eva Körner, Alexander Holl, Lucia Gruber, Franz Fazekas, Oskar Schröttner, Hans Eder, Erwin Ott
|
Seizure
|
2006 |
Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures
Yonatan Ganor, Miroslav Gottlieb, Raya Eilam, Hanoch Otmy, Vivian I. Teichberg, Mia Levite
|
Experimental Neurology
|
2005 |
Autoimmune epilepsy: Distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA
Yonatan Ganor, Hadassa Goldberg-Stern, Tally Lerman-Sagie, Vivian I. Teichberg, Mia Levite
|
Epilepsy Research
|
2005 |
Immunotherapy for epilepsy
Mia Levite, Ian K Hart
|
Expert Rev Neurotherapeutics
|
2002 |
IgG Isolated from LP-BM5 Infected Mouse Brain Activates Ionotropic Glutamate Receptors
Anthony S. Basile, Elena Koustova, P. Ioan, S. Rizzoli, Michael A. Rogawski, Peter N.R. Usherwood
|
Neurobiology of Disease
|
2001 |
|